Recent Advances in the Understanding of the Genetics, Etiology, and Treatment of Merkel Cell Carcinoma : ADVANCED CUTANEOUS MALIGNANCIESDONEPUDI, Sreekanth; DECONTI, Ronald C; SAMLOWSKI, Wolfram E et al.Seminars in oncology. 2012, Vol 39, Num 2, pp 163-172, issn 0093-7754, 10 p.Article

Management of renal cancer in the tyrosine kinase inhibitor era : a view from 3 years onSAMLOWSKI, Wolfram E; WONG, Bryan; VOGELZANG, Nicholas J et al.BJU international (Papier). 2008, Vol 102, Num 2, pp 162-165, issn 1464-4096, 4 p.Article

Patterns of enlarged lymph nodes in patients with metastatic renal cell carcinomaHADLEY, David A; STEPHENSON, Robert A; SAMLOWSKI, Wolfram E et al.Urologic oncology. 2011, Vol 29, Num 6, pp 751-755, issn 1078-1439, 5 p.Article

Inducible Nitric Oxide Synthase (iNOS) is Not Required for IL-2-induced Hypotension and Vascular Leak Syndrome in MiceKONDAPANENI, Muralidhar; MCGREGOR, John R; SALVEMINI, Daniela et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 4, pp 325-333, issn 1524-9557, 9 p.Article

A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic MelanomaWEBER, Jeffrey S; SAMLOWSKI, Wolfram E; GONZALEZ, Rene et al.Cancer. 2010, Vol 116, Num 15, pp 3683-3691, issn 0008-543X, 9 p.Article

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: A Southwest Oncology Group StudyWHITEHEAD, Robert P; MOON, James; MCCACHREN, S. Spence et al.Cancer. 2004, Vol 100, Num 8, pp 1699-1704, issn 0008-543X, 6 p.Article

Endothelial Nitric Oxide Synthase Is a Key Mediator of Interleukin-2-Induced Hypotension and Vascular Leak SyndromeSAMLOWSKI, Wolfram E; KONDAPANENI, Muralidhar; THARKAR, Shweta et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 5, pp 419-427, issn 1524-9557, 9 p.Article

Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS)SAMLOWSKI, Wolfram E; WATSON, Gordon A; WANG, Michael et al.Cancer. 2007, Vol 109, Num 9, pp 1855-1862, issn 0008-543X, 8 p.Article

ReGel® polymer-based delivery of interleukin-2 as a cancer treatmentSAMLOWSKI, Wolfram E; MCGREGOR, John R; JUREK, Maria et al.Journal of immunotherapy (1997). 2006, Vol 29, Num 5, pp 524-535, issn 1524-9557, 12 p.Article

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck : A Southwest Oncology Group Phase II studySAMLOWSKI, Wolfram E; GUNDACKER, Holly; KUEBLER, J. Philip et al.Investigational new drugs. 2001, Vol 19, Num 4, pp 311-315, issn 0167-6997Article

Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyVOGELZANG, Nicholas J; BENOWITZ, Steven I; PATEL, Jyoti D et al.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 88-109, issn 0732-183X, 22 p.Article

Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastasesMAJER, Martin; JENSEN, Randy L; SHRIEVE, Dennis C et al.Cancer. 2007, Vol 110, Num 6, pp 1329-1337, issn 0008-543X, 9 p.Article

N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in miceCOTTER, Murray A; THOMAS, Joshua; CASSIDY, Pamela et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5952-5958, issn 1078-0432, 7 p.Article

Longitudinal assessment of the nevus phenotype in a melanoma kindredFLORELL, Scott R; MEYER, Laurence J; ZONE, John J et al.Journal of investigative dermatology. 2004, Vol 123, Num 3, pp 576-582, issn 0022-202X, 7 p.Article

Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infantALEXANDER, April; SAMLOWSKI, Wolfram E; GROSSMAN, Douglas et al.Journal of clinical oncology. 2003, Vol 21, Num 11, pp 2179-2186, issn 0732-183X, 8 p.Article